66 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

2309

CMIC HOLDINGS
JP¥2,644.000.2%26.6%JP¥44.7bn/aPE8.4xn/a1.9%

4572

Carna Biosciences
JP¥311.004.4%-62.5%JP¥5.9bn/aPS4.2xn/an/a

4578

Otsuka Holdings
JP¥8,952.00-2.6%60.5%JP¥4.8tJP¥8,831.82PE31.8xE11.6%1.3%

4880

CellSource
JP¥1,150.001.7%-28.9%JP¥22.7bJP¥1,600.00PE36.6xE30.1%0.4%

4891

TMS
JP¥205.00-1.9%-18.7%JP¥8.3bJP¥760.00PB2.8xn/an/a

4547

Kissei Pharmaceutical
JP¥3,690.000%21.0%JP¥158.0bJP¥3,950.00PE14.7xE-5.3%2.4%

2183

Linical
JP¥345.00-4.4%-36.8%JP¥7.8bn/aPE30.8xn/a4.6%

4575

CanBas
JP¥850.00-7.4%-19.0%JP¥16.2bn/aPB5.1xn/an/a

4582

SymBio Pharmaceuticals
JP¥242.002.5%-11.4%JP¥11.1bn/aPS3.6xn/an/a

4519

Chugai Pharmaceutical
JP¥6,383.00-10.5%29.2%JP¥10.5tJP¥7,225.00PE27.1xE6.2%1.3%

4591

Ribomic
JP¥83.003.8%-30.3%JP¥3.4bn/aPS1686.7xn/an/a

4974

Takara Bio
JP¥1,053.00-5.6%-13.8%JP¥126.8bJP¥1,500.00PE139.5xE25.2%1.6%

4884

Kringle Pharma
JP¥860.005.4%12.1%JP¥5.8bn/aPS73.1xn/an/a

4568

Daiichi Sankyo Company
JP¥4,483.00-1.5%10.5%JP¥8.5tJP¥6,355.56PE33.8xE19.5%1.3%

190A

Chordia Therapeutics
JP¥223.005.2%n/aJP¥15.1bn/aPB3.6xn/an/a

4516

Nippon Shinyaku
JP¥4,154.002.2%-23.9%JP¥279.8bJP¥4,018.75PE10.7xE-10.1%3.0%

2397

DNA Chip Research
JP¥702.00-1.3%-1.8%JP¥4.8bn/aPS6.2xn/an/a

4536

Santen Pharmaceutical
JP¥1,664.00-1.5%22.6%JP¥576.3bJP¥2,103.00PE22.1xE11.5%2.0%

4151

Kyowa Kirin
JP¥2,545.00-0.9%3.4%JP¥1.3tJP¥3,283.33PE15.5xE6.1%2.3%

4881

FunPep
JP¥145.0010.7%-9.4%JP¥4.6bn/aPB2.2xn/an/a

4893

Noile-Immune Biotech
JP¥168.002.4%-57.8%JP¥7.3bJP¥440.00PS23.7xE-15.5%n/a

4530

Hisamitsu Pharmaceutical
JP¥4,284.001.1%-6.7%JP¥314.2bJP¥4,500.00PE21.4xE11.1%2.0%

4548

Seikagaku
JP¥817.000.9%8.1%JP¥44.6bn/aPE22.1xn/a3.7%

4598

Delta-Fly Pharma
JP¥523.00-23.0%-57.2%JP¥4.3bn/aPB5.9xn/an/a
Page 1 of 3
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.